Global Oncology & Cancer Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Description

The Oncology & Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Oncology & Cancer Drugs size is estimated to be  million in 2021 from USD  million in 2020, with a change of  % between 2020 and 2021. The global Oncology & Cancer Drugs market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
Oncology & Cancer Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Chemotherapy
    Targeted Therapy
    Immunotherapy (Biologic Therapy)
    Hormonal Therapy
    Others

Market segment by Application can be divided into
    Blood Cancer
    Breast Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Respiratory/Lung Cancer
    Others

The key market players for global Oncology & Cancer Drugs market are listed below:
    Roche
    Celgene
    Novartis
    Bristol-Myers Squibb
    Johnson & Johnson
    Merck & Co.
    AstraZeneca
    Pfizer
    Amgen
    Eli Lilly
    AbbVie
    Takeda
    Astellas
    Ipsen
    Sanofi
    Bayer
    Biogen Idec
    Teva
    Otsuka
    Eisai
    Merck KGaA
    Gilead Sciences

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Oncology & Cancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology & Cancer Drugs, with price, sales, revenue and global market share of Oncology & Cancer Drugs from 2019 to 2021.
Chapter 3, the Oncology & Cancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology & Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Oncology & Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Oncology & Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Oncology & Cancer Drugs Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Oncology & Cancer Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Chemotherapy
        1.2.3 Targeted Therapy
        1.2.4 Immunotherapy (Biologic Therapy)
        1.2.5 Hormonal Therapy
        1.2.6 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Oncology & Cancer Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Blood Cancer
        1.3.3 Breast Cancer
        1.3.4 Gastrointestinal Cancer
        1.3.5 Prostate Cancer
        1.3.6 Respiratory/Lung Cancer
        1.3.7 Others
    1.4 Global Oncology & Cancer Drugs Market Size & Forecast
        1.4.1 Global Oncology & Cancer Drugs Sales in Value (2016-2026))
        1.4.2 Global Oncology & Cancer Drugs Sales in Volume (2016-2026)
        1.4.3 Global Oncology & Cancer Drugs Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Oncology & Cancer Drugs Production Capacity Analysis
        1.5.1 Global Oncology & Cancer Drugs Total Production Capacity (2016-2026)
        1.5.2 Global Oncology & Cancer Drugs Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Oncology & Cancer Drugs Market Drivers
        1.6.2 Oncology & Cancer Drugs Market Restraints
        1.6.3 Oncology & Cancer Drugs Trends Analysis

2 Manufacturers Profiles
    2.1 Roche
        2.1.1 Roche Details
        2.1.2 Roche Major Business
        2.1.3 Roche Oncology & Cancer Drugs Product and Services
        2.1.4 Roche Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Celgene
        2.2.1 Celgene Details
        2.2.2 Celgene Major Business
        2.2.3 Celgene Oncology & Cancer Drugs Product and Services
        2.2.4 Celgene Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Oncology & Cancer Drugs Product and Services
        2.3.4 Novartis Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Bristol-Myers Squibb
        2.4.1 Bristol-Myers Squibb Details
        2.4.2 Bristol-Myers Squibb Major Business
        2.4.3 Bristol-Myers Squibb Oncology & Cancer Drugs Product and Services
        2.4.4 Bristol-Myers Squibb Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Johnson & Johnson
        2.5.1 Johnson & Johnson Details
        2.5.2 Johnson & Johnson Major Business
        2.5.3 Johnson & Johnson Oncology & Cancer Drugs Product and Services
        2.5.4 Johnson & Johnson Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Merck & Co.
        2.6.1 Merck & Co. Details
        2.6.2 Merck & Co. Major Business
        2.6.3 Merck & Co. Oncology & Cancer Drugs Product and Services
        2.6.4 Merck & Co. Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 AstraZeneca
        2.7.1 AstraZeneca Details
        2.7.2 AstraZeneca Major Business
        2.7.3 AstraZeneca Oncology & Cancer Drugs Product and Services
        2.7.4 AstraZeneca Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Pfizer
        2.8.1 Pfizer Details
        2.8.2 Pfizer Major Business
        2.8.3 Pfizer Oncology & Cancer Drugs Product and Services
        2.8.4 Pfizer Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Amgen
        2.9.1 Amgen Details
        2.9.2 Amgen Major Business
        2.9.3 Amgen Oncology & Cancer Drugs Product and Services
        2.9.4 Amgen Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Eli Lilly
        2.10.1 Eli Lilly Details
        2.10.2 Eli Lilly Major Business
        2.10.3 Eli Lilly Oncology & Cancer Drugs Product and Services
        2.10.4 Eli Lilly Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 AbbVie
        2.11.1 AbbVie Details
        2.11.2 AbbVie Major Business
        2.11.3 AbbVie Oncology & Cancer Drugs Product and Services
        2.11.4 AbbVie Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 Takeda
        2.12.1 Takeda Details
        2.12.2 Takeda Major Business
        2.12.3 Takeda Oncology & Cancer Drugs Product and Services
        2.12.4 Takeda Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.13 Astellas
        2.13.1 Astellas Details
        2.13.2 Astellas Major Business
        2.13.3 Astellas Oncology & Cancer Drugs Product and Services
        2.13.4 Astellas Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.14 Ipsen
        2.14.1 Ipsen Details
        2.14.2 Ipsen Major Business
        2.14.3 Ipsen Oncology & Cancer Drugs Product and Services
        2.14.4 Ipsen Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.15 Sanofi
        2.15.1 Sanofi Details
        2.15.2 Sanofi Major Business
        2.15.3 Sanofi Oncology & Cancer Drugs Product and Services
        2.15.4 Sanofi Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.16 Bayer
        2.16.1 Bayer Details
        2.16.2 Bayer Major Business
        2.16.3 Bayer Oncology & Cancer Drugs Product and Services
        2.16.4 Bayer Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.17 Biogen Idec
        2.17.1 Biogen Idec Details
        2.17.2 Biogen Idec Major Business
        2.17.3 Biogen Idec Oncology & Cancer Drugs Product and Services
        2.17.4 Biogen Idec Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.18 Teva
        2.18.1 Teva Details
        2.18.2 Teva Major Business
        2.18.3 Teva Oncology & Cancer Drugs Product and Services
        2.18.4 Teva Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.19 Otsuka
        2.19.1 Otsuka Details
        2.19.2 Otsuka Major Business
        2.19.3 Otsuka Oncology & Cancer Drugs Product and Services
        2.19.4 Otsuka Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.20 Eisai
        2.20.1 Eisai Details
        2.20.2 Eisai Major Business
        2.20.3 Eisai Oncology & Cancer Drugs Product and Services
        2.20.4 Eisai Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.21 Merck KGaA
        2.21.1 Merck KGaA Details
        2.21.2 Merck KGaA Major Business
        2.21.3 Merck KGaA Oncology & Cancer Drugs Product and Services
        2.21.4 Merck KGaA Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.22 Gilead Sciences
        2.22.1 Gilead Sciences Details
        2.22.2 Gilead Sciences Major Business
        2.22.3 Gilead Sciences Oncology & Cancer Drugs Product and Services
        2.22.4 Gilead Sciences Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Oncology & Cancer Drugs Sales by Manufacturer
    3.1 Global Oncology & Cancer Drugs Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Oncology & Cancer Drugs Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Oncology & Cancer Drugs
    3.4 Market Concentration Rate
        3.4.1 Top 3 Oncology & Cancer Drugs Manufacturer Market Share
        3.4.2 Top 6 Oncology & Cancer Drugs Manufacturer Market Share
    3.5 Global Oncology & Cancer Drugs Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Oncology & Cancer Drugs Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Oncology & Cancer Drugs Market Size by Region
        4.1.1 Global Oncology & Cancer Drugs Sales in Volume by Region (2016-2026)
        4.1.2 Global Oncology & Cancer Drugs Revenue by Region (2016-2026)
    4.2 North America Oncology & Cancer Drugs Revenue (2016-2026)
    4.3 Europe Oncology & Cancer Drugs Revenue (2016-2026)
    4.4 Asia-Pacific Oncology & Cancer Drugs Revenue (2016-2026)
    4.5 South America Oncology & Cancer Drugs Revenue (2016-2026)
    4.6 Middle East and Africa Oncology & Cancer Drugs Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Oncology & Cancer Drugs Sales in Volume by Type (2016-2026)
    5.2 Global Oncology & Cancer Drugs Revenue by Type (2016-2026)
    5.3 Global Oncology & Cancer Drugs Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Oncology & Cancer Drugs Sales in Volume by Application (2016-2026)
    6.2 Global Oncology & Cancer Drugs Revenue by Application (2016-2026)
    6.3 Global Oncology & Cancer Drugs Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Oncology & Cancer Drugs Sales by Type (2016-2026)
    7.2 North America Oncology & Cancer Drugs Sales by Application (2016-2026)
    7.3 North America Oncology & Cancer Drugs Market Size by Country
        7.3.1 North America Oncology & Cancer Drugs Sales in Volume by Country (2016-2026)
        7.3.2 North America Oncology & Cancer Drugs Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Oncology & Cancer Drugs Sales by Type (2016-2026)
    8.2 Europe Oncology & Cancer Drugs Sales by Application (2016-2026)
    8.3 Europe Oncology & Cancer Drugs Market Size by Country
        8.3.1 Europe Oncology & Cancer Drugs Sales in Volume by Country (2016-2026)
        8.3.2 Europe Oncology & Cancer Drugs Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Oncology & Cancer Drugs Sales by Type (2016-2026)
    9.2 Asia-Pacific Oncology & Cancer Drugs Sales by Application (2016-2026)
    9.3 Asia-Pacific Oncology & Cancer Drugs Market Size by Region
        9.3.1 Asia-Pacific Oncology & Cancer Drugs Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Oncology & Cancer Drugs Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Oncology & Cancer Drugs Sales by Type (2016-2026)
    10.2 South America Oncology & Cancer Drugs Sales by Application (2016-2026)
    10.3 South America Oncology & Cancer Drugs Market Size by Country
        10.3.1 South America Oncology & Cancer Drugs Sales in Volume by Country (2016-2026)
        10.3.2 South America Oncology & Cancer Drugs Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Oncology & Cancer Drugs Sales by Type (2016-2026)
    11.2 Middle East & Africa Oncology & Cancer Drugs Sales by Application (2016-2026)
    11.3 Middle East & Africa Oncology & Cancer Drugs Market Size by Country
        11.3.1 Middle East & Africa Oncology & Cancer Drugs Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Oncology & Cancer Drugs Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Oncology & Cancer Drugs Typical Distributors
    12.3 Oncology & Cancer Drugs Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oncology & Cancer Drugs Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Oncology & Cancer Drugs Revenue by Application, (USD Million), 2021-2026
    Table 3. Roche Basic Information, Manufacturing Base and Competitors
    Table 4. Roche Major Business
    Table 5. Roche Oncology & Cancer Drugs Product and Services
    Table 6. Roche Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Celgene Basic Information, Manufacturing Base and Competitors
    Table 8. Celgene Major Business
    Table 9. Celgene Oncology & Cancer Drugs Product and Services
    Table 10. Celgene Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Novartis Basic Information, Manufacturing Base and Competitors
    Table 12. Novartis Major Business
    Table 13. Novartis Oncology & Cancer Drugs Product and Services
    Table 14. Novartis Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 16. Bristol-Myers Squibb Major Business
    Table 17. Bristol-Myers Squibb Oncology & Cancer Drugs Product and Services
    Table 18. Bristol-Myers Squibb Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 20. Johnson & Johnson Major Business
    Table 21. Johnson & Johnson Oncology & Cancer Drugs Product and Services
    Table 22. Johnson & Johnson Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Merck & Co. Basic Information, Manufacturing Base and Competitors
    Table 24. Merck & Co. Major Business
    Table 25. Merck & Co. Oncology & Cancer Drugs Product and Services
    Table 26. Merck & Co. Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 28. AstraZeneca Major Business
    Table 29. AstraZeneca Oncology & Cancer Drugs Product and Services
    Table 30. AstraZeneca Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 32. Pfizer Major Business
    Table 33. Pfizer Oncology & Cancer Drugs Product and Services
    Table 34. Pfizer Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Amgen Basic Information, Manufacturing Base and Competitors
    Table 36. Amgen Major Business
    Table 37. Amgen Oncology & Cancer Drugs Product and Services
    Table 38. Amgen Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 40. Eli Lilly Major Business
    Table 41. Eli Lilly Oncology & Cancer Drugs Product and Services
    Table 42. Eli Lilly Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. AbbVie Basic Information, Manufacturing Base and Competitors
    Table 44. AbbVie Major Business
    Table 45. AbbVie Oncology & Cancer Drugs Product and Services
    Table 46. AbbVie Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. Takeda Basic Information, Manufacturing Base and Competitors
    Table 48. Takeda Major Business
    Table 49. Takeda Oncology & Cancer Drugs Product and Services
    Table 50. Takeda Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 51. Astellas Basic Information, Manufacturing Base and Competitors
    Table 52. Astellas Major Business
    Table 53. Astellas Oncology & Cancer Drugs Product and Services
    Table 54. Astellas Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 55. Ipsen Basic Information, Manufacturing Base and Competitors
    Table 56. Ipsen Major Business
    Table 57. Ipsen Oncology & Cancer Drugs Product and Services
    Table 58. Ipsen Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 59. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 60. Sanofi Major Business
    Table 61. Sanofi Oncology & Cancer Drugs Product and Services
    Table 62. Sanofi Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 63. Bayer Basic Information, Manufacturing Base and Competitors
    Table 64. Bayer Major Business
    Table 65. Bayer Oncology & Cancer Drugs Product and Services
    Table 66. Bayer Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 67. Biogen Idec Basic Information, Manufacturing Base and Competitors
    Table 68. Biogen Idec Major Business
    Table 69. Biogen Idec Oncology & Cancer Drugs Product and Services
    Table 70. Biogen Idec Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 71. Teva Basic Information, Manufacturing Base and Competitors
    Table 72. Teva Major Business
    Table 73. Teva Oncology & Cancer Drugs Product and Services
    Table 74. Teva Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 75. Otsuka Basic Information, Manufacturing Base and Competitors
    Table 76. Otsuka Major Business
    Table 77. Otsuka Oncology & Cancer Drugs Product and Services
    Table 78. Otsuka Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 79. Eisai Basic Information, Manufacturing Base and Competitors
    Table 80. Eisai Major Business
    Table 81. Eisai Oncology & Cancer Drugs Product and Services
    Table 82. Eisai Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 83. Merck KGaA Basic Information, Manufacturing Base and Competitors
    Table 84. Merck KGaA Major Business
    Table 85. Merck KGaA Oncology & Cancer Drugs Product and Services
    Table 86. Merck KGaA Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 87. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 88. Gilead Sciences Major Business
    Table 89. Gilead Sciences Oncology & Cancer Drugs Product and Services
    Table 90. Gilead Sciences Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 91. Global Oncology & Cancer Drugs Sales by Manufacturer (2019-2021e) & (K Units)
    Table 92. Global Oncology & Cancer Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 93. Market Position of Manufacturers in Oncology & Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 94. Global Oncology & Cancer Drugs Production Capacity by Company, (K Units): 2020 VS 2021
    Table 95. Head Office and Oncology & Cancer Drugs Production Site of Key Manufacturer
    Table 96. Oncology & Cancer Drugs New Entrant and Capacity Expansion Plans
    Table 97. Oncology & Cancer Drugs Mergers & Acquisitions in the Past Five Years
    Table 98. Global Oncology & Cancer Drugs Sales by Region (2016-2021e) & (K Units)
    Table 99. Global Oncology & Cancer Drugs Sales by Region (2021-2026) & (K Units)
    Table 100. Global Oncology & Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
    Table 101. Global Oncology & Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
    Table 102. Global Oncology & Cancer Drugs Sales by Type (2016-2021e) & (K Units)
    Table 103. Global Oncology & Cancer Drugs Sales by Type (2021-2026) & (K Units)
    Table 104. Global Oncology & Cancer Drugs Revenue by Type (2016-2021e) & (USD Million)
    Table 105. Global Oncology & Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
    Table 106. Global Oncology & Cancer Drugs Price by Type (2016-2021e) & (US$/Unit)
    Table 107. Global Oncology & Cancer Drugs Price by Type (2021-2026) & (US$/Unit)
    Table 108. Global Oncology & Cancer Drugs Sales by Application (2016-2021e) & (K Units)
    Table 109. Global Oncology & Cancer Drugs Sales by Application (2021-2026) & (K Units)
    Table 110. Global Oncology & Cancer Drugs Revenue by Application (2016-2021e) & (USD Million)
    Table 111. Global Oncology & Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
    Table 112. Global Oncology & Cancer Drugs Price by Application (2016-2021e) & (US$/Unit)
    Table 113. Global Oncology & Cancer Drugs Price by Application (2021-2026) & (US$/Unit)
    Table 114. North America Oncology & Cancer Drugs Sales by Country (2016-2021e) & (K Units)
    Table 115. North America Oncology & Cancer Drugs Sales by Country (2021-2026) & (K Units)
    Table 116. North America Oncology & Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
    Table 117. North America Oncology & Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
    Table 118. North America Oncology & Cancer Drugs Sales by Type (2016-2021e) & (K Units)
    Table 119. North America Oncology & Cancer Drugs Sales by Type (2021-2026) & (K Units)
    Table 120. North America Oncology & Cancer Drugs Sales by Application (2016-2021e) & (K Units)
    Table 121. North America Oncology & Cancer Drugs Sales by Application (2021-2026) & (K Units)
    Table 122. Europe Oncology & Cancer Drugs Sales by Country (2016-2021e) & (K Units)
    Table 123. Europe Oncology & Cancer Drugs Sales by Country (2021-2026) & (K Units)
    Table 124. Europe Oncology & Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
    Table 125. Europe Oncology & Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
    Table 126. Europe Oncology & Cancer Drugs Sales by Type (2016-2021e) & (K Units)
    Table 127. Europe Oncology & Cancer Drugs Sales by Type (2021-2026) & (K Units)
    Table 128. Europe Oncology & Cancer Drugs Sales by Application (2016-2021e) & (K Units)
    Table 129. Europe Oncology & Cancer Drugs Sales by Application (2021-2026) & (K Units)
    Table 130. Asia-Pacific Oncology & Cancer Drugs Sales by Region (2016-2021e) & (K Units)
    Table 131. Asia-Pacific Oncology & Cancer Drugs Sales by Region (2021-2026) & (K Units)
    Table 132. Asia-Pacific Oncology & Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
    Table 133. Asia-Pacific Oncology & Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
    Table 134. Asia-Pacific Oncology & Cancer Drugs Sales by Type (2016-2021e) & (K Units)
    Table 135. Asia-Pacific Oncology & Cancer Drugs Sales by Type (2021-2026) & (K Units)
    Table 136. Asia-Pacific Oncology & Cancer Drugs Sales by Application (2016-2021e) & (K Units)
    Table 137. Asia-Pacific Oncology & Cancer Drugs Sales by Application (2021-2026) & (K Units)
    Table 138. South America Oncology & Cancer Drugs Sales by Country (2016-2021e) & (K Units)
    Table 139. South America Oncology & Cancer Drugs Sales by Country (2021-2026) & (K Units)
    Table 140. South America Oncology & Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
    Table 141. South America Oncology & Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
    Table 142. South America Oncology & Cancer Drugs Sales by Type (2016-2021e) & (K Units)
    Table 143. South America Oncology & Cancer Drugs Sales by Type (2021-2026) & (K Units)
    Table 144. South America Oncology & Cancer Drugs Sales by Application (2016-2021e) & (K Units)
    Table 145. South America Oncology & Cancer Drugs Sales by Application (2021-2026) & (K Units)
    Table 146. Middle East & Africa Oncology & Cancer Drugs Sales by Country (2016-2021e) & (K Units)
    Table 147. Middle East & Africa Oncology & Cancer Drugs Sales by Country (2021-2026) & (K Units)
    Table 148. Middle East & Africa Oncology & Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
    Table 149. Middle East & Africa Oncology & Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
    Table 150. Middle East & Africa Oncology & Cancer Drugs Sales by Type (2016-2021e) & (K Units)
    Table 151. Middle East & Africa Oncology & Cancer Drugs Sales by Type (2021-2026) & (K Units)
    Table 152. Middle East & Africa Oncology & Cancer Drugs Sales by Application (2016-2021e) & (K Units)
    Table 153. Middle East & Africa Oncology & Cancer Drugs Sales by Application (2021-2026) & (K Units)
    Table 154. Direct Channel Pros & Cons
    Table 155. Indirect Channel Pros & Cons
    Table 156. Oncology & Cancer Drugs Typical Distributors
    Table 157. Oncology & Cancer Drugs Typical Customers
List of Figures
    Figure 1. Oncology & Cancer Drugs Picture
    Figure 2. Global Oncology & Cancer Drugs Sales Market Share by Type in 2020
    Figure 3. Chemotherapy
    Figure 4. Targeted Therapy
    Figure 5. Immunotherapy (Biologic Therapy)
    Figure 6. Hormonal Therapy
    Figure 7. Others
    Figure 8. Global Oncology & Cancer Drugs Sales Market Share by Application in 2020
    Figure 9. Blood Cancer
    Figure 10. Breast Cancer
    Figure 11. Gastrointestinal Cancer
    Figure 12. Prostate Cancer
    Figure 13. Respiratory/Lung Cancer
    Figure 14. Others
    Figure 15. Global Oncology & Cancer Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 16. Global Oncology & Cancer Drugs Market Size and Forecast (2016-2026) & (USD Million)
    Figure 17. Global Oncology & Cancer Drugs Sales (2016-2026) & (K Units)
    Figure 18. Global Oncology & Cancer Drugs Price by Type (2016-2026) & (US$/Unit)
    Figure 19. Global Oncology & Cancer Drugs Production Capacity (2016-2026) & (K Units)
    Figure 20. Global Oncology & Cancer Drugs Production Capacity by Geographic Region: 2020 VS 2021
    Figure 21. Oncology & Cancer Drugs Market Drivers
    Figure 22. Oncology & Cancer Drugs Market Restraints
    Figure 23. Oncology & Cancer Drugs Market Trends
    Figure 24. Global Oncology & Cancer Drugs Sales Market Share by Manufacturer in 2020
    Figure 25. Global Oncology & Cancer Drugs Revenue Market Share by Manufacturer in 2020
    Figure 26. Oncology & Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 27. Top 3 Oncology & Cancer Drugs Manufacturer (Revenue) Market Share in 2020
    Figure 28. Top 6 Oncology & Cancer Drugs Manufacturer (Revenue) Market Share in 2020
    Figure 29. Global Oncology & Cancer Drugs Sales Market Share by Region (2016-2026)
    Figure 30. Global Oncology & Cancer Drugs Revenue Market Share by Region (2016-2026)
    Figure 31. North America Oncology & Cancer Drugs Revenue (2016-2026) & (USD Million)
    Figure 32. Europe Oncology & Cancer Drugs Revenue (2016-2026) & (USD Million)
    Figure 33. Asia-Pacific Oncology & Cancer Drugs Revenue (2016-2026) & (USD Million)
    Figure 34. South America Oncology & Cancer Drugs Revenue (2016-2026) & (USD Million)
    Figure 35. Middle East & Africa Oncology & Cancer Drugs Revenue (2016-2026) & (USD Million)
    Figure 36. Global Oncology & Cancer Drugs Sales Market Share by Type (2016-2026)
    Figure 37. Global Oncology & Cancer Drugs Revenue Market Share by Type (2016-2026)
    Figure 38. Global Oncology & Cancer Drugs Price by Type (2016-2026) & (US$/Unit)
    Figure 39. Global Oncology & Cancer Drugs Sales Market Share by Application (2016-2026)
    Figure 40. Global Oncology & Cancer Drugs Revenue Market Share by Application (2016-2026)
    Figure 41. Global Oncology & Cancer Drugs Price by Application (2016-2026) & (US$/Unit)
    Figure 42. North America Oncology & Cancer Drugs Sales Market Share by Type (2016-2026)
    Figure 43. North America Oncology & Cancer Drugs Sales Market Share by Application (2016-2026)
    Figure 44. North America Oncology & Cancer Drugs Sales Market Share by Country (2016-2026)
    Figure 45. North America Oncology & Cancer Drugs Revenue Market Share by Country (2016-2026)
    Figure 46. United States Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. Canada Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. Mexico Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Europe Oncology & Cancer Drugs Sales Market Share by Type (2016-2026)
    Figure 50. Europe Oncology & Cancer Drugs Sales Market Share by Application (2016-2026)
    Figure 51. Europe Oncology & Cancer Drugs Sales Market Share by Country (2016-2026)
    Figure 52. Europe Oncology & Cancer Drugs Revenue Market Share by Country (2016-2026)
    Figure 53. Germany Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. France Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. United Kingdom Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Russia Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Italy Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Asia-Pacific Oncology & Cancer Drugs Sales Market Share by Region (2016-2026)
    Figure 59. Asia-Pacific Oncology & Cancer Drugs Sales Market Share by Application (2016-2026)
    Figure 60. Asia-Pacific Oncology & Cancer Drugs Sales Market Share by Region (2016-2026)
    Figure 61. Asia-Pacific Oncology & Cancer Drugs Revenue Market Share by Region (2016-2026)
    Figure 62. China Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Japan Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Korea Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. India Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Southeast Asia Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Australia Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. South America Oncology & Cancer Drugs Sales Market Share by Type (2016-2026)
    Figure 69. South America Oncology & Cancer Drugs Sales Market Share by Application (2016-2026)
    Figure 70. South America Oncology & Cancer Drugs Sales Market Share by Country (2016-2026)
    Figure 71. South America Oncology & Cancer Drugs Revenue Market Share by Country (2016-2026)
    Figure 72. Brazil Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Argentina Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Type (2016-2026)
    Figure 75. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Application (2016-2026)
    Figure 76. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Country (2016-2026)
    Figure 77. Middle East & Africa Oncology & Cancer Drugs Revenue Market Share by Country (2016-2026)
    Figure 78. Turkey Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Egypt Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. Saudi Arabia Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 81. South Africa Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 82. Sales Channel: Direct Channel vs Indirect Channel
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Companies Mentioned

Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences